Activation of DNA-PK by ionizing radiation is mediated by protein phosphatase 6.

by Jun Mi, Jaroslaw Dziegielewski, Elzbieta Bolesta, David L Brautigan, James M Larner
Published 2009-01-01

Low‐dose hilar and mediastinal stereotactic body radiation therapy for non‐small cell lung cancer: Analysis of outcomes in patients receiving one or multiple courses of treatment...

by Roman O. Kowalchuk, Michael R. Waters, Martin Richardson, Kelly Spencer, James M. Larner, Charles R. Kersh
Published 2020-07-01

Stereotactic body radiation therapy in the treatment of ovarian cancer

by Roman O. Kowalchuk, Michael R. Waters, K. Martin Richardson, Kelly Spencer, James M. Larner, William P. Irvin, Charles R. Kersh
Published 2020-05-01

Cyclophilin B Expression Is Associated with In Vitro Radioresistance and Clinical Outcome after Radiotherapy

by Paul D. Williams, Charles R. Owens, Jaroslaw Dziegielewski, Christopher A. Moskaluk, Paul W. Read, James M. Larner, Michael D. Story, William A. Brock, Sally A. Amundson, Jae K. Lee, Dan Theodorescu
Published 2011-12-01

Recursive Partitioning Analysis for Local Control Achieved With Stereotactic Body Radiation Therapy for the Liver, Spine, or Lymph Nodes

by Roman O. Kowalchuk, MD, Michael R. Waters, MD, PhD, Sunil W. Dutta, MD, Marie L. Mack, BS, K. Martin Richardson, MS, Kelly Spencer, MS, Kara D. Romano, MD, James M. Larner, MD, Jason P. Sheehan, MD, PhD, C. Ronald Kersh, MD
Published 2021-05-01